NMRA · Neumora Therapeutics, Inc. · Exempt Offerings
$0.33
-0.01 (-3.78%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Nov 16, 2026
Market Cap
$63.01M
Shares
188.69M
Volume · Nov 20
1.06M
Avg daily vol (3M)
1.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
143 filings
117 filers
Visit website
Investor relations